Is this an investment that disease and genetics researchers believe will be valuable?
Or is this primarily tax deductible funds flowing back into the AI industrial complex?
(Honest question! If it’s a truly promising path that’s great)
Or is this primarily tax deductible funds flowing back into the AI industrial complex?
(Honest question! If it’s a truly promising path that’s great)
A lot of parties.